Interleukin-2-fc fusion proteins and methods of use

MYPI2025003149A0Undetermined Publication Date: 2022-04-22GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025003149
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-04-28
Filing Date
2021-10-20
Publication Date
2022-04-22
Patent Text Reader

Abstract

INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USE Provided are serum half-life extended-IL-2 variant (IL-2v) heterodimers having reduced binding to the IL2Rα (CD25) subunit. In particular, Fc-IL-2v heterodimers are provided and methods for making and using, e.g. for enhancing an immune response, e.g. in the prevention and treatment of viral infections and cancer. Figure 19
Need to check novelty before this filing date? Find Prior Art